Molecular Medicine & Pathology seminar: Molecular Determinants of Response to Hormonal Therapy in Breast Cancer Event as iCalendar

22 August 2013

3:30 - 4:30pm

Venue: Seminar Room 501-505, Building 501, 85 Park Road, Grafton

Although most oestrogen receptor positive (ER+ve) breast cancer patients are now diagnosed at an early stage and have a good prognosis, the disease is frequently both under- and over-treated. Consequently, there is a need for better predictive and prognostic biomarkers. We have profiled tumours fromĀ ER+ve patients to identify molecular features of response and new targets for therapies.

Presented by: Dr Anita Dunbier , Department of Biochemistry, University of Otago

For more information or anyone wanting to meet with Dr Anita Dunbier should email Robyn McDonald email: